Telaprevir

Details

Files

Generic Name:

Telaprevir

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Vertex Pharmaceuticals Inc.

Call for patient/clinician input open:

August 16, 2011

Brand Name:

Incivek

Project Line:

Reimbursement Review

Project Number:

SR0249-000

Call for patient/clinician input closed:

September 14, 2011

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Hepatitis C infection (genotype 1), Chronic

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

February 15, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : August 23, 2011